Variant report

Variant	nsv978132
Chromosome Location	chr16:30635969-30640484
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:284)
CpG islands
(count:0)
Chromatin interactive
region (count:25)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:284 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:30640087-30640377	K562	blood:	n/a	n/a
2	ATF1	chr16:30640099-30640425	K562	blood:	n/a	n/a
3	BCLAF1	chr16:30640010-30640496	GM12878	blood:	n/a	n/a
4	BHLHE40	chr16:30640108-30640421	K562	blood:	n/a	n/a
5	BHLHE40	chr16:30640134-30640385	GM12878	blood:	n/a	n/a
6	CBX3	chr16:30639884-30640466	K562	blood:	n/a	n/a
7	CHD2	chr16:30640191-30640333	HepG2	liver:	n/a	n/a
8	CHD2	chr16:30640189-30640355	GM12878	blood:	n/a	n/a
9	CREB1	chr16:30640143-30640314	A549	lung:	n/a	n/a
10	CTCF	chr16:30640180-30640330	AG04450	lung:	n/a	n/a
11	CTCF	chr16:30640200-30640350	GM06990	blood:	n/a	n/a
12	CTCF	chr16:30640076-30640441	A549	lung:	n/a	n/a
13	CTCF	chr16:30640200-30640350	NB4	blood:	n/a	n/a
14	CTCF	chr16:30640160-30640310	HUVEC	blood vessel:	n/a	n/a
15	CTCF	chr16:30640200-30640350	HPAF	blood vessel:	n/a	n/a
16	CTCF	chr16:30640180-30640330	AG09309	skin:	n/a	n/a
17	CTCF	chr16:30640048-30640463	IMR90	lung:	n/a	n/a
18	CTCF	chr16:30640200-30640350	HCPEpiC	choroid plexus:	n/a	n/a
19	CTCF	chr16:30640180-30640330	GM12867	blood:	n/a	n/a
20	CTCF	chr16:30640041-30640416	HepG2	liver:	n/a	n/a
21	CTCF	chr16:30640200-30640350	SAEC	small airway:	n/a	n/a
22	CTCF	chr16:30640220-30640370	HVMF	connective:	n/a	n/a
23	CTCF	chr16:30640180-30640330	GM12865	blood:	n/a	n/a
24	CTCF	chr16:30640200-30640350	HEK293	kidney:	n/a	n/a
25	CTCF	chr16:30640180-30640330	HPAF	blood vessel:	n/a	n/a
26	CTCF	chr16:30640200-30640350	Hela-S3	cervix:	n/a	n/a
27	CTCF	chr16:30640180-30640330	GM12872	blood:	n/a	n/a
28	CTCF	chr16:30640090-30640394	A549	lung:	n/a	n/a
29	CTCF	chr16:30640131-30640387	GM12892	blood:	n/a	n/a
30	CTCF	chr16:30640180-30640330	GM12864	blood:	n/a	n/a
31	CTCF	chr16:30640150-30640374	MCF-7	breast:	n/a	n/a
32	CTCF	chr16:30640140-30640378	GM12891	blood:	n/a	n/a
33	CTCF	chr16:30640180-30640330	GM12870	blood:	n/a	n/a
34	CTCF	chr16:30640180-30640330	WERI-Rb-1	eye:	n/a	n/a
35	CTCF	chr16:30639963-30640547	MCF-7	breast:	n/a	n/a
36	CTCF	chr16:30640180-30640330	HAc	cerebellar:	n/a	n/a
37	CTCF	chr16:30640063-30640492	T-47D	breast:	n/a	n/a
38	CTCF	chr16:30640200-30640350	GM12865	blood:	n/a	n/a
39	CTCF	chr16:30640160-30640310	HL-60	blood:	n/a	n/a
40	CTCF	chr16:30639895-30640569	A549	lung:	n/a	n/a
41	CTCF	chr16:30640159-30640366	MCF-7	breast:	n/a	n/a
42	CTCF	chr16:30640140-30640290	Hela-S3	cervix:	n/a	n/a
43	CTCF	chr16:30640180-30640330	GM12875	blood:	n/a	n/a
44	CTCF	chr16:30640180-30640330	HPF	lung:	n/a	n/a
45	CTCF	chr16:30640135-30640385	A549	lung:	n/a	n/a
46	CTCF	chr16:30640046-30640477	GM12878	blood:	n/a	n/a
47	CTCF	chr16:30640180-30640330	NHEK	skin:	n/a	n/a
48	CTCF	chr16:30640180-30640330	MCF-7	breast:	n/a	n/a
49	CTCF	chr16:30640200-30640350	GM12866	blood:	n/a	n/a
50	CTCF	chr16:30640123-30640399	GM19238	blood:	n/a	n/a

No data

(count:25 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:30639009..30641962-chr16:30644620..30646873,2	MCF-7	breast:
2	chr16:30461088..30461625-chr16:30639966..30640472,2	K562	blood:
3	chr16:30640289..30641957-chr16:30643938..30645571,2	K562	blood:
4	chr16:30535774..30538341-chr16:30638616..30641301,3	MCF-7	breast:
5	chr16:30438921..30441839-chr16:30640349..30642308,3	MCF-7	breast:
6	chr16:30631964..30634523-chr16:30638900..30640577,2	MCF-7	breast:
7	chr16:30609228..30610120-chr16:30639831..30640577,2	MCF-7	breast:
8	chr16:30595303..30597100-chr16:30638655..30641608,2	MCF-7	breast:
9	chr16:30620089..30622285-chr16:30635751..30637347,2	MCF-7	breast:
10	chr16:30370896..30371772-chr16:30640037..30640734,2	MCF-7	breast:
11	chr16:30420686..30421384-chr16:30639848..30640409,3	K562	blood:
12	chr16:30635973..30637940-chr16:30671557..30674235,2	MCF-7	breast:
13	chr16:30441187..30442115-chr16:30639784..30640702,8	MCF-7	breast:
14	chr16:30441457..30442175-chr16:30639765..30640742,5	MCF-7	breast:
15	chr16:30609239..30609773-chr16:30640020..30640552,2	K562	blood:
16	chr16:30555913..30558805-chr16:30639399..30642318,2	K562	blood:
17	chr16:30638840..30641606-chr16:30661205..30662742,2	MCF-7	breast:
18	chr16:30640409..30642631-chr16:30670637..30672923,2	MCF-7	breast:
19	chr16:30621055..30622609-chr16:30640051..30642203,2	MCF-7	breast:
20	chr16:30640142..30641957-chr16:30643713..30645899,3	K562	blood:
21	chr16:30617317..30620136-chr16:30639446..30642000,2	K562	blood:
22	chr16:30454893..30456842-chr16:30638548..30640357,2	K562	blood:
23	chr16:30441082..30442394-chr16:30639571..30640733,5	K562	blood:
24	chr16:30439565..30443046-chr16:30640159..30642380,3	MCF-7	breast:
25	chr16:30429607..30431783-chr16:30638612..30641034,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PRR14-5	chr16:30638297-30638499	NONHSAT141785

No data

Variant related genes	Relation type
ENSG00000260113	TF binding region
ZNF689	TF binding region
ENSG00000261680	TF binding region
ENSG00000156858	chromatin interactions
ENSG00000169221	chromatin interactions
ENSG00000169957	chromatin interactions
ENSG00000199787	chromatin interactions
ENSG00000197162	chromatin interactions
ENSG00000179958	chromatin interactions
ENSG00000156860	chromatin interactions
ENSG00000156853	chromatin interactions

Extended variants
information (count: 171 )
Associated
traits (count: 119 )

Variant overlapped rSNPs/rCNVs (count:171 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs528644046	chr16:30636007-30636008	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs543362104	chr16:30636103-30636104	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs112125457	chr16:30636139-30636140	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs190057779	chr16:30636140-30636141	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs540793517	chr16:30636152-30636153	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs182329318	chr16:30636172-30636173	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs533280500	chr16:30636219-30636220	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs537519715	chr16:30636220-30636221	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs563576112	chr16:30636230-30636231	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs565899729	chr16:30636231-30636232	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs529830109	chr16:30636259-30636260	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs530891666	chr16:30636262-30636263	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs141205258	chr16:30636270-30636271	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs150734579	chr16:30636290-30636291	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs528710432	chr16:30636291-30636292	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs547248700	chr16:30636294-30636295	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs139136651	chr16:30636321-30636322	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs184805586	chr16:30636342-30636343	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs548486906	chr16:30636349-30636350	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs569554299	chr16:30636359-30636360	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs537023281	chr16:30636361-30636362	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs142350039	chr16:30636364-30636365	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs146039199	chr16:30636398-30636399	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs540907600	chr16:30636405-30636406	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs139964686	chr16:30636415-30636416	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs577408916	chr16:30636443-30636444	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs149737109	chr16:30636474-30636475	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs563752918	chr16:30636486-30636487	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs188143730	chr16:30636543-30636544	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs372174856	chr16:30636602-30636603	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs181002488	chr16:30636605-30636606	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs4485386	chr16:30636611-30636612	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs547309257	chr16:30636630-30636631	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs185113091	chr16:30636631-30636632	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs4366718	chr16:30636632-30636633	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs373040128	chr16:30636683-30636684	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs532692563	chr16:30636716-30636717	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs551210339	chr16:30636724-30636725	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs7191389	chr16:30636737-30636738	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs558086887	chr16:30636772-30636773	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs7499339	chr16:30636777-30636778	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs142890054	chr16:30636806-30636807	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs113024433	chr16:30636808-30636809	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs552780087	chr16:30636819-30636820	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs574997134	chr16:30636839-30636840	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs577417440	chr16:30636868-30636869	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs538796220	chr16:30636877-30636878	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs111639166	chr16:30636893-30636894	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs112764986	chr16:30636946-30636947	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs79236865	chr16:30636959-30636960	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:119)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Lung cancer	18438408	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic myeloid leukemia	21384125	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:162 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:30631400-30640000	Weak transcription	Fetal Brain Male	brain
2	chr16:30631800-30640000	Weak transcription	Fetal Intestine Large	intestine
3	chr16:30632400-30636000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr16:30632600-30636200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
5	chr16:30633400-30636000	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr16:30633800-30636000	Enhancers	K562	blood
7	chr16:30634200-30640000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr16:30634400-30640000	Weak transcription	Fetal Kidney	kidney
9	chr16:30634600-30636000	ZNF genes & repeats	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr16:30634600-30640000	Weak transcription	Fetal Intestine Small	intestine
11	chr16:30634600-30640000	Weak transcription	Hela-S3	cervix
12	chr16:30634800-30636000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr16:30635000-30636000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr16:30635200-30636000	Enhancers	Placenta	Placenta
15	chr16:30635200-30636000	Enhancers	HMEC	breast
16	chr16:30635200-30640000	Weak transcription	Liver	Liver
17	chr16:30635600-30636000	Enhancers	Duodenum Mucosa	Duodenum
18	chr16:30635600-30636000	Enhancers	NHEK	skin
19	chr16:30635800-30636000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr16:30635800-30636000	Flanking Bivalent TSS/Enh	HepG2	liver
21	chr16:30636000-30636200	Bivalent Enhancer	HepG2	liver
22	chr16:30636000-30639400	Weak transcription	Placenta	Placenta
23	chr16:30636000-30639400	Weak transcription	K562	blood
24	chr16:30636000-30639800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
25	chr16:30636000-30639800	Weak transcription	Duodenum Mucosa	Duodenum
26	chr16:30636000-30640000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr16:30636000-30640000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr16:30636000-30640000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr16:30636000-30640000	Weak transcription	NHEK	skin
30	chr16:30636200-30640000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr16:30637600-30637800	Flanking Active TSS	HepG2	liver
32	chr16:30637800-30638000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr16:30637800-30638000	Enhancers	HepG2	liver
34	chr16:30638000-30638200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr16:30638000-30638200	Enhancers	Brain Hippocampus Middle	brain
36	chr16:30638000-30638200	Flanking Active TSS	HepG2	liver
37	chr16:30638000-30640000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr16:30638200-30640000	Weak transcription	Brain Hippocampus Middle	brain
39	chr16:30638200-30642000	Enhancers	HepG2	liver
40	chr16:30638200-30645000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr16:30638600-30640000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
42	chr16:30638600-30640000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr16:30638800-30639000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr16:30639400-30639600	Flanking Active TSS	Placenta	Placenta
45	chr16:30639400-30640000	Active TSS	Skeletal Muscle Male	skeletal muscle
46	chr16:30639400-30640000	Enhancers	K562	blood
47	chr16:30639400-30640600	Enhancers	Dnd41	blood
48	chr16:30639600-30640200	Active TSS	Colonic Mucosa	Colon
49	chr16:30639600-30640200	Active TSS	Placenta	Placenta
50	chr16:30639800-30640000	Active TSS	Breast Myoepithelial Primary Cells	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links